For: | Lesmana CRA. Impact of endoscopic ultrasound-guided radiofrequency ablation in managing pancreatic malignancy. World J Gastrointest Surg 2023; 15(2): 163-168 [PMID: 36896311 DOI: 10.4240/wjgs.v15.i2.163] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v15/i2/163.htm |
Number | Citing Articles |
1 |
Joan B. Gornals. EUS-guided radiofrequency ablation in pancreatic cancer: Promising but still questionable!. Gastrointestinal Endoscopy 2024; 100(2): 259 doi: 10.1016/j.gie.2024.04.022
|
2 |
Kerui Pan, Sisi Wang, Xueping Li, Shuoming Wu, Ashraf Elbahrawy. Efficacy and safety of ultrasound-guided radiofrequency ablation combined with transhepatic artery embolization chemotherapy for hepatocellular carcinoma: A meta-analysis. PLOS ONE 2024; 19(9): e0305965 doi: 10.1371/journal.pone.0305965
|
3 |
Alejandra Vargas, Priyata Dutta, Eileen S. Carpenter, Jorge D. Machicado. Endoscopic Ultrasound-Guided Ablation of Premalignant Pancreatic Cysts and Pancreatic Cancer. Diagnostics 2024; 14(5): 564 doi: 10.3390/diagnostics14050564
|
4 |
Hironari KATO, Kazuyuki MATSUMOTO. Current status of endoscopic ultrasound (EUS)-guided ablation therapy for pancreatic neuroendocrine neoplasms (PNENs). Suizo 2023; 38(4): 229 doi: 10.2958/suizo.38.229
|
5 |
Cosmas Rinaldi Adithya Lesmana. Endoscopic loco-regional treatment in controlling pancreatic neuroendocrine tumors (PNETs) behavior: a case series and literature review. Clinical Journal of Gastroenterology 2024; 17(4): 754 doi: 10.1007/s12328-024-01959-2
|